
256: Explaining the E.U.'s pharma overhaul, Lilly's booming business, & a long-awaited drug approval
The Readout Loud
00:00
The Politics of Investing in Europe
Drug companies say they don't need to invest in Europe. And if the regulatory climate goes a certain way, they will invest elsewhere. It's kind of very familiar because drug companies said similar things in the United States over the years and most recently with the proposal for Medicare to negotiate the prices of certain drugs here in this country. Damien: I'm not exactly sure how to square that or reconcile that.
Transcript
Play full episode